Preclinical evaluation of new taxoids.

Bissery, M C

Bissery, M C.

Affiliation

Bissery MC; Pathology and In Vivo Models, Oncology Disease Group, Aventis Pharma Group, Aventis Pharma S.A., 13, quai Jules Guesde, Vitry-sur-Seine, F-94403, France. marie-christine.bissery@aventis.com

Curr Pharm Des ; 7(13): 1251-7, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11472265

Subject(s)

Antineoplastic Agents, Phytogenic/therapeutic use; Bridged-Ring Compounds/therapeutic use; Neoplasms, Experimental/drug therapy; Paclitaxel/analogs & derivatives; Paclitaxel/therapeutic use; Taxoids; Animals; Docetaxel

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bridged-Ring Compounds / Paclitaxel / Taxoids / Neoplasms, Experimental / Antineoplastic Agents, Phytogenic Limits: Animals Language: En Journal: Curr Pharm Des Journal subject: FARMACIA Year: 2001 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links